It's time to lace up the sneakers for March Madness! For the first time, you can come to work comfortably in your sneakers while fighting back against cancer at the same time. On Wednesday, March 20, associates at Kohler Co. will have the opportunity to pay $5 to wear sneakers to work, or $10 to wear sneakers AND favorite team apparel. 100% of the profits benefit the American Cancer Society's Coaches vs. Cancer Bo Ryan - Jay Holliday Families Fund.
The Coaches vs. Cancer Bo Ryan - Jay Holliday Families Fund was established in 2018 in honor of Coach Ryan's longtime friend and former college roommate, Jay Holliday, who lost his battle with pancreatic cancer. All dollars raised for the Coaches vs. Cancer Bo Ryan - Jay Holliday Families Fund are restricted to American Cancer Society-funded research at the Carbone Cancer Center. Currently, two researchers at Carbone have been selected to receive funding thanks to this Fund:
· Randall J. Kimple, MD, PhD, Therapy Induced Autophagy in Head and Neck Cancer Patients: Head and neck cancer is typically associated with advanced stage diagnosis, high recurrence rates, and poor long-term outcomes – survival rates for this cancer have not improved over the past decade. Dr. Kimple’s research will use tissue samples to study the resistance of head and neck cancer cells to a specific chemotherapy drug, as well as analyze whether treatment for head and neck cancers with that drug should include another drug(s) to help block the cancer’s resistance to this type of chemotherapy.
· Pamela K. Kreeger, PhD, Inhibition of Metastasis in Ovarian Cancer: Ovarian cancer is often diagnosed at a late stage and after the disease has spread (metastasized) to other abdominal organs or tissue. Dr. Kreeger’s research will study the efficacy of an FDA-approved drug in slowing or stopping metastases by blocking the production and function of a protein known to enable ovarian cancer cells easily attaching to other parts of the abdomen. These results will then allow Dr. Kreeger to identify any biomarkers that could help further identify those patients who would benefit most from this approach.
Thanks for joining in the March Madness and fighting back against cancer!